August J. Troendle Insider Trading $CHRS Coherus BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for August J. Troendle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of August J. Troendle. August J. Troendle is Director in Coherus BioSciences, Inc. ($CHRS) and President & CEO in Medpace Holdings, Inc. ($MEDP).
August J. Troendle in Coherus BioSciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of August J. Troendle: Director
Holdings: 29,994 shares
Current Value: $799,340
Latest Transaction: Feb 05 2018
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of August J. Troendle in Coherus BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2018 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | A | 10.05 | 20,000 | 201,000 | 20,000 | |
| May 26 2016 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
| Feb 11 2016 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | M | 0.42 | 8,124 | 3,386 | 0 | |
| Feb 11 2016 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | M | 0.42 | 8,124 | 3,386 | 29,994 | 21.9 K to 30 K (+37.15 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 35.15 | 860 | 30,233 | 268,428 | 269.3 K to 268.4 K (-0.32 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 34.09 | 24,809 | 845,729 | 269,288 | 294.1 K to 269.3 K (-8.44 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 33.77 | 62,442 | 2,108,492 | 294,097 | 356.5 K to 294.1 K (-17.51 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 32.22 | 1,889 | 60,872 | 356,539 | 358.4 K to 356.5 K (-0.53 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 35.15 | 2,370 | 83,315 | 1,642,492 | 1.6 M to 1.6 M (-0.14 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 34.09 | 68,941 | 2,350,178 | 1,644,862 | 1.7 M to 1.6 M (-4.02 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 33.77 | 173,440 | 5,856,601 | 1,713,803 | 1.9 M to 1.7 M (-9.19 %) |
| Aug 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 32.22 | 5,249 | 169,145 | 1,887,243 | 1.9 M to 1.9 M (-0.28 %) |
| Jun 16 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 27.08 | 2,376 | 64,331 | 1,892,492 | 1.9 M to 1.9 M (-0.13 %) |
| Jun 16 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 26.62 | 111,606 | 2,970,583 | 1,894,868 | 2 M to 1.9 M (-5.56 %) |
| Jun 16 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 27.29 | 1,851 | 50,512 | 2,006,474 | 2 M to 2 M (-0.09 %) |
| Jun 16 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Sell | S | 26.72 | 134,167 | 3,585,251 | 2,008,325 | 2.1 M to 2 M (-6.26 %) |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 358,428 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 266,502 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 1,556,055 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | C | 0.00 | 319,935 | 0 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | X | 0.00 | 107,528 | 0 | 1,556,055 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Option Exercise | X | 0.02 | 107,528 | 1,796 | 0 | |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 358,428 | 0 | 358,428 | 0 to 358.4 K |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 266,502 | 0 | 2,142,492 | 1.9 M to 2.1 M (+14.21 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 1,556,055 | 0 | 1,875,990 | 319.9 K to 1.9 M (+486.37 %) |
| Nov 12 2014 | CHRS | Coherus BioScience ... | Troendle August J. | Director | Buy | C | 0.00 | 319,935 | 0 | 319,935 | 0 to 319.9 K |
Page: 1